Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Sutton

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Haematologica|September 29, 2018
Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemiaPanagiotis Baliakas, Theodoros Moysiadis, Anastasia Hadzidimitriou, et al.
Blood Advances|January 25, 2023
BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinibSilvia Bonfiglio, Lesley-Ann Sutton, Viktor Ljungström, et al.
Blood Advances|August 23, 2021
Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disordersJames Peter Stewart, Jana Gazdova, Nikos Darzentas, et al.
Haematologica|December 23, 2017
No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapyPanagiotis Baliakas, Mattias Mattsson, Anastasia Hadzidimitriou, et al.
The Journal of Pathology|November 29, 2018
Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferationsAliki Xochelli, Vasilis Bikos, Eleftheria Polychronidou, et al.
Blood|January 31, 2015
Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerationsPanagiotis Baliakas, Andreas Agathangelidis, Anastasia Hadzidimitriou, et al.
The Lancet. Haematology|April 1, 2016
Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre studyPanagiotis Baliakas, Anastasia Hadzidimitriou, Lesley-Ann Sutton, et al.
The Journal of Clinical Investigation|December 12, 2017
Drug-perturbation-based stratification of blood cancerSascha Dietrich, Małgorzata Oleś, Junyan Lu, et al.
Leukemia|April 24, 2025
ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarkerBirna Thorvaldsdottir, Larry Mansouri, Lesley-Ann Sutton, et al.
Blood Advances|May 27, 2026
Integrated multi-omic profiling reveals two distinct splenic marginal zone lymphoma subgroups with prognostic relevanceHelen Parker, Amatta Mirandari, Ben Stevens, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Haematologica|September 29, 2018
Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemiaPanagiotis Baliakas, Theodoros Moysiadis, Anastasia Hadzidimitriou, et al.
Blood Advances|January 25, 2023
BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinibSilvia Bonfiglio, Lesley-Ann Sutton, Viktor Ljungström, et al.
Blood Advances|August 23, 2021
Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disordersJames Peter Stewart, Jana Gazdova, Nikos Darzentas, et al.
Haematologica|December 23, 2017
No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapyPanagiotis Baliakas, Mattias Mattsson, Anastasia Hadzidimitriou, et al.
The Journal of Pathology|November 29, 2018
Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferationsAliki Xochelli, Vasilis Bikos, Eleftheria Polychronidou, et al.
Blood|January 31, 2015
Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerationsPanagiotis Baliakas, Andreas Agathangelidis, Anastasia Hadzidimitriou, et al.
The Lancet. Haematology|April 1, 2016
Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre studyPanagiotis Baliakas, Anastasia Hadzidimitriou, Lesley-Ann Sutton, et al.
The Journal of Clinical Investigation|December 12, 2017
Drug-perturbation-based stratification of blood cancerSascha Dietrich, Małgorzata Oleś, Junyan Lu, et al.
Leukemia|April 24, 2025
ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarkerBirna Thorvaldsdottir, Larry Mansouri, Lesley-Ann Sutton, et al.
Blood Advances|May 27, 2026
Integrated multi-omic profiling reveals two distinct splenic marginal zone lymphoma subgroups with prognostic relevanceHelen Parker, Amatta Mirandari, Ben Stevens, et al.
Pageof 10